Zoetis Inc. logo

Zoetis Inc. (ZOE)

Market Closed
17 Jul, 15:30
XETRA XETRA
67. 22
-0.14
-0.2078%
- Market Cap
29.76 P/E Ratio
2.12% Div Yield
350 Volume
5.79 Eps
67.36
Previous Close
Add Transaction
Day Range
67 67.72
Year Range
62.7 137.14
Want to track ZOE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ZOE closed yesterday lower at €67.22, a decrease of -0.2078% from Thursday's close, completing a monthly increase of 0.3284% or €0.22. Over the past 12 months, ZOE stock lost -37.9202%.
ZOE pays dividends to its shareholders, with the most recent payment made on Jun 02, 2026. The next announced payment will be in In 1 month on Sep 01, 2026 for a total of €0.53.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.6196%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ZOE Chart

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

Zoetis (ZTS) closed at $74.07 in the latest trading session, marking a -1.75% move from the prior day.

Zacks | 4 days ago
Zoetis: Buy When There Is Blood In The Streets

Zoetis: Buy When There Is Blood In The Streets

Zoetis has long been viewed as a high-quality compounder. However, after reaching an all-time high of $249.27 in December 2021, the stock is now caught in a ~70% drawdown. This can be primarily attributed to the dismal performance of the company's crown jewel asset, namely the U.S. companion animal business. After delivering an impressive 25% organic growth during the full year of 2021, the U.S. companion animal business reported dismal performance in Q1-26, with an organic decline of 11%.

Seekingalpha | 4 days ago
ZTS Wins European Commission Approval for New Poultry Disease Vaccine

ZTS Wins European Commission Approval for New Poultry Disease Vaccine

Zoetis wins EU approval for a single-dose poultry vaccine against Newcastle and Marek's diseases, expanding its vaccine portfolio and flock protection options.

Zacks | 1 week ago

Zoetis Inc. (ZOE) FAQ

What is the stock price today?

The current price is €67.22.

On which exchange is it traded?

Zoetis Inc. is listed on XETRA.

What is its stock symbol?

The ticker symbol is ZOE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.12%.

What is its market cap?

As of today, no market cap data is available.

Has Zoetis Inc. ever had a stock split?

No, there has never been a stock split.

Zoetis Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Kristin C. Peck CEO
XETRA Exchange
98978V103 CUSIP
US Country
13,800 Employees
20 Jul 2026 Last Dividend
- Last Split
1 Feb 2013 IPO Date

Overview

Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of a wide range of animal health medicines, vaccines, and diagnostic products. Founded in 1952 and based in Parsippany, New Jersey, the company addresses the health needs of both livestock—including cattle, swine, poultry, fish, and sheep—and companion animals, such as dogs, cats, and horses. With a presence in both the United States and international markets, Zoetis delivers products and services designed to meet the complex challenges of animal health, ensuring the well-being of animals across the globe. The company's extensive product line-up, alongside innovative diagnostic solutions, makes it a vital player in promoting animal health and supporting the veterinarians, livestock producers, and pet owners who care for them.

Products and Services

Zoetis Inc. offers an expansive portfolio of products and services designed to enhance animal health and support the professionals who work with animals. These include:

  • Vaccines: Zoetis provides biological preparations that protect against diseases of the respiratory, gastrointestinal, and reproductive tracts. These vaccines induce a specific immune response in a variety of animals, helping prevent outbreaks and the spread of infectious diseases in both livestock and companion animals.
  • Anti-infectives: These products are formulated to prevent, kill, or slow the growth of harmful bacteria, fungi, or protozoa. By offering a range of anti-infectives, Zoetis contributes to the overall health and well-being of animals, helping to combat infections before they become widespread issues.
  • Parasiticides: To protect animals from external and internal parasites, Zoetis commercializes treatments that eliminate or prevent infestations such as fleas, ticks, and worms. These products are critical in maintaining animal health and preventing the transmission of parasite-borne diseases to other animals and humans.
  • Other Pharmaceutical Products: Beyond vaccines and parasiticides, Zoetis offers a variety of pharmaceutical products addressing pain and sedation, antiemetic therapies, reproductive health, and oncology in animals. Additionally, the company provides dermatology products for conditions such as allergic dermatitis, ensuring comprehensive care for a wide range of health needs.
  • Medicated Feed Additives: These products mix medicines with livestock feed to prevent or treat disease and enhance overall animal health. Medicated feed additives are a critical component in the maintenance of healthy commercial herds and flocks.
  • Diagnostic Products: Zoetis delivers a variety of diagnostic solutions, including portable blood and urine analysis testing kits, point-of-care products, and instruments. These diagnostic tools are vital for early detection of disease and condition management in animal healthcare settings.
  • Non-Pharmaceutical Products and Services: In addition to its pharmaceutical offerings, Zoetis provides nutritionals and agribusiness services, products for biodevices, genetic tests, and precision animal health solutions. These products and services support the broader aspects of animal care and health management.

Contact Information

Address: 10 Sylvan Way
Phone: 973 822 7000